The Cancer Research Institute of Montpellier U1194 jointly operated by Inserm, University of Montpellier (UM) and Institut du Cancer de Montpellier (ICM)
• 280 scientists and support personnel
• 19 research teams sharing 5000 m2 of lab space
• Excellent core facilities, many being part of the shared facilities network Montpellier BioCampus
• Ground breaking research in basic and translational oncology developed in close collaboration with clinical departments and clinical research at ICM
One central theme and two unifying programs : Molecular Targets and Cancer Therapy
1. Plasticity of solid tumors : from discoveries to personalized medecine
2. Therapeutic Antibodies in Cancer Treatment : Innovation, design and biological response
Director - N.Bonnefoy
Deputy Directors - L.Le Cam
Administrative Manager - C.Rodriguez
Medical Advisor - D.Azria